6 Patents
- US126166962026Crystalline Forms of (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2′-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5′,6-dimethyl-2h-[1,4′-bipyridin]-2-one
Aclaris Therapeutics, Inc.
0 cites - US123847572025Methods of Synthesizing Substituted Pyridinone-pyridinyl Compounds
Aclaris Therapeutics, Inc.
0 cites - US123701952025Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
Aclaris Therapeutics, Inc.
0 cites - 0 cites
- US118448012023Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
Aclaris Therapeutics, Inc.
0 cites - US117673092023Methods of Synthesizing Substituted Pyridinone-pyridinyl Compounds
Aclaris Therapeutics, Inc.
0 cites